| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/12/2004 | WO2004067767A1 Method of screening cell death modulators. |
| 08/12/2004 | WO2004067751A1 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 08/12/2004 | WO2004067750A2 Xenorhabdus tc proteins and genes for pest control |
| 08/12/2004 | WO2004067744A1 Self-replication determining factor of embryonic stem cell |
| 08/12/2004 | WO2004067734A1 Method for determining the influence of a test substance on the heart activity of a vertebrate |
| 08/12/2004 | WO2004067733A1 Improvements in and relating to cell growth |
| 08/12/2004 | WO2004067732A2 Polymer carriers with bonded saccharides for immobilization of biological systems |
| 08/12/2004 | WO2004067704A2 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | WO2004067697A2 Icos+ suppresser t cells |
| 08/12/2004 | WO2004067696A2 Interspecies embryonic stem cells |
| 08/12/2004 | WO2004067571A1 Monoclonal antibody against human hepatoma and use thereof |
| 08/12/2004 | WO2004067025A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | WO2004066942A2 Purification and uses of dendritic cells and monocytes |
| 08/12/2004 | WO2004066937A2 Antibodies specific for plasmacytoid dendritic cells |
| 08/12/2004 | WO2004066724A1 Transgenic animal having fatty acid desaturase and method of producing the same |
| 08/12/2004 | WO2004056265A3 Device and method for non-invasive measurement of the individual metabolic rate of a substantially spherical metabolizing particle |
| 08/12/2004 | WO2004053144A3 Modulation of stem cell differentiation by modulation of caspase-3 activity |
| 08/12/2004 | WO2004050680A3 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 08/12/2004 | WO2004035607A3 Human monoclonal antibodies against cd20 |
| 08/12/2004 | WO2004026250A3 Re-activated t-cells for adoptive immunotherapy |
| 08/12/2004 | WO2004015071A3 CSNK1GS AS MODIFIERS OF THE p21 PATHWAY AND METHODS OF USE |
| 08/12/2004 | WO2004011611A3 Taci antibodies and uses thereof |
| 08/12/2004 | WO2003079977A3 Novel compositions and methods in cancer associated with altered expression of mcm3ap |
| 08/12/2004 | WO2003066804A3 Thermus scotoductus nucleic acid polymerases |
| 08/12/2004 | WO2003048337A3 Antibody to latent membrane proteins and uses thereof |
| 08/12/2004 | WO2003042693A3 Method for measuring intracellular atp and/or gene expression |
| 08/12/2004 | WO2003039484A3 Novel compositions and methods for cancer |
| 08/12/2004 | WO2003037060A3 Compositions and methods for wt1 specific immunotherapy |
| 08/12/2004 | WO2003032913A3 Methods and compositions for targeting proteins across the blood brain barrier |
| 08/12/2004 | WO2003029293A3 Modulators of notch ic protease activity for use in immunotherapy |
| 08/12/2004 | WO2003023028A9 Fungal glyoxal oxidases |
| 08/12/2004 | WO2002090504A3 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use |
| 08/12/2004 | WO2002077179A8 Leinamycin biosynthesis gene cluster and its components and their uses |
| 08/12/2004 | WO2002071927A9 Diagnosis and treatment of skeletal degeneration conditions |
| 08/12/2004 | WO2002057408A3 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 08/12/2004 | US20040158891 Comprises nucleotide sequences coding senescence induced hydrolase in antisense orientation for generating plants with prolonged life or shelf life, flowering, reduced fruit spoilage, seed aging and/or reduced yellowing of leaves |
| 08/12/2004 | US20040158883 Animal model for identification of modulators and treatments of obsessive-compulsive (OCD), attention deficit/hyperactivity (ADHD), mood, learning and sleep disorders |
| 08/12/2004 | US20040158045 Nucleotide sequences coding tumor necrosis factor binding proteins for prevention and treatment of bone disorders |
| 08/12/2004 | US20040158044 Comprises polypeptide which binds major histocompatibility complex for use in cancer diagnosis and treatment; antitumor agents |
| 08/12/2004 | US20040158039 Secreted proteins |
| 08/12/2004 | US20040157788 production of antibodies containing K light chains, in order to provide high affinity reproducibly |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157328 Carrier for cell culture |
| 08/12/2004 | US20040157326 Promoters of the growth and/or differentiation of hematopoietic stem cells and/or hematopoietic progenitors |
| 08/12/2004 | US20040157325 Bone marrow cell differentiation |
| 08/12/2004 | US20040157324 Method for maintenance and propagation of germline stem cells using members of the TGF-beta family of growth factors |
| 08/12/2004 | US20040157323 Biomaterial derived from vertebrate liver tissue |
| 08/12/2004 | US20040157322 Multi-sample fermentor and method of using same |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157305 obtained from Rhodococcus; biocatalyst; stereospecific alcohol dehydrogenase activity in the oxidation of secondary alcohols or the reduction of ketones |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157299 by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulating protein; for multi-transduced cells for multi-targeted therapy; genetic engineering |
| 08/12/2004 | US20040157295 Canine dioxin/aryl hydrocarbon receptor sequences |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157291 expressed sequence tag (EST); of fusion proteins comprising the first N-terminal domain of the geneIII protein of filamentous phage as fusion partner for the expression of a fused (poly)peptide/protein |
| 08/12/2004 | US20040157287 Gene switches; polypeptides and promoter; induce transcription |
| 08/12/2004 | US20040157286 Process for producing coenzymes q10 |
| 08/12/2004 | US20040157283 by in vitro culture; can be utilized to mimic the natural in vivo environments of those tissue source organs for drug screening |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040156864 Immunogenic HBc chimer particles having enhanced stability |
| 08/12/2004 | US20040156860 T-cell vaccination for the treatment of multiple sclerosis |
| 08/12/2004 | US20040156842 Uses of human Zven antagonists |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/12/2004 | US20040156834 use in bone marrow transplantation, into bone marrow cavity or into extraskeletal sites, such as the kidney capsule, muscles, liver, abdominal wall; treatment of diseases affecting the stromal microenvironment that controls hematopoiesis |
| 08/12/2004 | US20040156833 Devices and methods for implanting transduced cells |
| 08/12/2004 | US20040156832 vector for reverting cell lines to a pro-B cell-like state or to a germline-like state; generating immunoglobulins including immunoglobulin heavy and/or light chains and generating libraries of cells that produce arrays of immunoglobulins |
| 08/12/2004 | US20040156826 Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues |
| 08/12/2004 | CA2514474A1 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | CA2513598A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | CA2510267A1 Antibodies specific for plasmacytoid dendritic cells |
| 08/11/2004 | EP1445322A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/11/2004 | EP1445319A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 08/11/2004 | EP1445311A1 Method of amplyfying hematopoietic stem cells |
| 08/11/2004 | EP1444994A1 Method of forming normal regenerated tissue, the normal regenerated tissue, and method of calibrating senstivity and so on |
| 08/11/2004 | EP1444986A1 Pharmaceutical preparation for the improved treatment of blood-clotting disorders |
| 08/11/2004 | EP1444985A2 Use of follistatin for the manufacture of a medicament for the treatment of a non-degenerative nervous system disorder |
| 08/11/2004 | EP1444349A2 Process for the preparation of ramipril |
| 08/11/2004 | EP1444346A2 Sirna knockout assay method and constructs |
| 08/11/2004 | EP1444345A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 08/11/2004 | EP1444340A2 Transgenic mice knockout for histamine receptor h3 gene |
| 08/11/2004 | EP1444335A2 Mutant purine nucleoside phosphorylase proteins and cellular delivery thereof |
| 08/11/2004 | EP1444331A2 Novel cell-based assays for g-protein-coupled receptor-mediated activities |
| 08/11/2004 | EP1444330A1 Expansion of t cells in vitro and expanded t cell populations |
| 08/11/2004 | EP1444329A2 Stem cells that transform to beating cardiomyocytes |
| 08/11/2004 | EP1444328A2 Induction of beta cell differentiation in human cells |
| 08/11/2004 | EP1444326A2 Screening assays for identifying differentiation-inducing agents and production of differentiated cells for cell therapy |
| 08/11/2004 | EP1444325A1 Methods and devices for the integrated discovery of cell culture environments |
| 08/11/2004 | EP1444267A2 Affinity enhancement agents |
| 08/11/2004 | EP1444262A2 Growth hormone variations in humans and their uses |
| 08/11/2004 | EP1444245A2 Novel chromophores/fluorophores and methods for using the same |
| 08/11/2004 | EP1443988A1 Device for and method of controlled enzymatic removal and retrieval of tissue |
| 08/11/2004 | EP1443983A1 Nerve repair unit and method of producing it |
| 08/11/2004 | EP1443970A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 08/11/2004 | EP1443961A2 Glycoprotein compositions |